vs
DOMO, INC.(DOMO)与Nutex Health, Inc.(NUTX)财务数据对比。点击上方公司名可切换其他公司
Nutex Health, Inc.的季度营收约是DOMO, INC.的1.9倍($151.7M vs $79.4M),Nutex Health, Inc.净利率更高(7.8% vs -13.1%,领先20.9%),DOMO, INC.同比增速更快(-0.5% vs -41.1%),Nutex Health, Inc.自由现金流更多($69.0M vs $1.1M),过去两年Nutex Health, Inc.的营收复合增速更高(50.0% vs -0.5%)
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业,主营人工智能、商业智能与数据可视化业务,属于SaaS(软件即服务)企业,核心产品可帮助企业各层级决策者在极少IT介入的情况下,实时获取业务数据,支撑决策开展。
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业,核心业务为运营各类医疗机构,是美国本土医疗领域的专业运营机构,致力于为当地市场提供相关医疗服务与场地运营支持。
DOMO vs NUTX — 直观对比
营收规模更大
NUTX
是对方的1.9倍
$79.4M
营收增速更快
DOMO
高出40.7%
-41.1%
净利率更高
NUTX
高出20.9%
-13.1%
自由现金流更多
NUTX
多$67.9M
$1.1M
两年增速更快
NUTX
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $79.4M | $151.7M |
| 净利润 | $-10.4M | $11.8M |
| 毛利率 | 74.2% | 30.4% |
| 营业利润率 | -8.7% | 20.4% |
| 净利率 | -13.1% | 7.8% |
| 营收同比 | -0.5% | -41.1% |
| 净利润同比 | 44.6% | -80.8% |
| 每股收益(稀释后) | $-0.25 | $2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOMO
NUTX
| Q4 25 | $79.4M | $151.7M | ||
| Q3 25 | $79.7M | $267.8M | ||
| Q2 25 | $80.1M | $244.0M | ||
| Q1 25 | $78.8M | $211.8M | ||
| Q4 24 | $79.8M | $257.6M | ||
| Q3 24 | $78.4M | $78.8M | ||
| Q2 24 | $80.1M | $76.1M | ||
| Q1 24 | $80.2M | $67.5M |
净利润
DOMO
NUTX
| Q4 25 | $-10.4M | $11.8M | ||
| Q3 25 | $-22.9M | $55.4M | ||
| Q2 25 | $-18.1M | $-17.7M | ||
| Q1 25 | $-17.7M | $21.2M | ||
| Q4 24 | $-18.8M | $61.6M | ||
| Q3 24 | $-19.5M | $-8.8M | ||
| Q2 24 | $-26.0M | $-364.0K | ||
| Q1 24 | $-18.7M | $-364.0K |
毛利率
DOMO
NUTX
| Q4 25 | 74.2% | 30.4% | ||
| Q3 25 | 74.8% | 57.8% | ||
| Q2 25 | 74.2% | 51.2% | ||
| Q1 25 | 74.4% | 55.9% | ||
| Q4 24 | 75.0% | 55.0% | ||
| Q3 24 | 74.3% | 27.8% | ||
| Q2 24 | 74.1% | 29.7% | ||
| Q1 24 | 76.3% | 15.1% |
营业利润率
DOMO
NUTX
| Q4 25 | -8.7% | 20.4% | ||
| Q3 25 | -9.1% | 48.7% | ||
| Q2 25 | -17.9% | 13.8% | ||
| Q1 25 | -15.6% | 38.1% | ||
| Q4 24 | -13.9% | 44.4% | ||
| Q3 24 | -18.5% | 12.3% | ||
| Q2 24 | -26.8% | 7.0% | ||
| Q1 24 | -16.6% | 2.1% |
净利率
DOMO
NUTX
| Q4 25 | -13.1% | 7.8% | ||
| Q3 25 | -28.8% | 20.7% | ||
| Q2 25 | -22.5% | -7.3% | ||
| Q1 25 | -22.4% | 10.0% | ||
| Q4 24 | -23.5% | 23.9% | ||
| Q3 24 | -24.9% | -11.2% | ||
| Q2 24 | -32.5% | -0.5% | ||
| Q1 24 | -23.3% | -0.5% |
每股收益(稀释后)
DOMO
NUTX
| Q4 25 | $-0.25 | $2.34 | ||
| Q3 25 | $-0.56 | $7.76 | ||
| Q2 25 | $-0.45 | $-2.95 | ||
| Q1 25 | $-0.45 | $3.33 | ||
| Q4 24 | $-0.48 | $11.56 | ||
| Q3 24 | $-0.51 | $-1.72 | ||
| Q2 24 | $-0.69 | $-0.07 | ||
| Q1 24 | $-0.51 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $185.6M |
| 总债务越低越好 | $124.2M | — |
| 股东权益账面价值 | $-191.9M | $329.4M |
| 总资产 | $201.6M | $918.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DOMO
NUTX
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | $47.2M | $96.7M | ||
| Q1 25 | $45.3M | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | $61.2M | $40.8M | ||
| Q1 24 | $60.9M | $30.0M |
总债务
DOMO
NUTX
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
股东权益
DOMO
NUTX
| Q4 25 | $-191.9M | $329.4M | ||
| Q3 25 | $-191.5M | $317.2M | ||
| Q2 25 | $-178.7M | $235.3M | ||
| Q1 25 | $-177.2M | $176.9M | ||
| Q4 24 | $-171.2M | $132.4M | ||
| Q3 24 | $-166.4M | $60.4M | ||
| Q2 24 | $-163.5M | $62.7M | ||
| Q1 24 | $-153.5M | $63.0M |
总资产
DOMO
NUTX
| Q4 25 | $201.6M | $918.5M | ||
| Q3 25 | $195.7M | $964.5M | ||
| Q2 25 | $189.7M | $841.0M | ||
| Q1 25 | $214.3M | $761.9M | ||
| Q4 24 | $190.2M | $655.3M | ||
| Q3 24 | $197.8M | $438.5M | ||
| Q2 24 | $204.4M | $422.4M | ||
| Q1 24 | $225.7M | $404.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.4M | $70.4M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $69.0M |
| 自由现金流率自由现金流/营收 | 1.4% | 45.5% |
| 资本支出强度资本支出/营收 | 2.9% | 0.9% |
| 现金转化率经营现金流/净利润 | — | 5.95× |
| 过去12个月自由现金流最近4个季度 | $9.9M | $245.6M |
8季度趋势,按日历期对齐
经营现金流
DOMO
NUTX
| Q4 25 | $3.4M | $70.4M | ||
| Q3 25 | $3.4M | $99.5M | ||
| Q2 25 | $4.0M | $27.3M | ||
| Q1 25 | $8.9M | $51.0M | ||
| Q4 24 | $-13.7M | $54.0K | ||
| Q3 24 | $-6.2M | $6.8M | ||
| Q2 24 | $1.9M | $13.3M | ||
| Q1 24 | $5.4M | $3.1M |
自由现金流
DOMO
NUTX
| Q4 25 | $1.1M | $69.0M | ||
| Q3 25 | $1.0M | $99.2M | ||
| Q2 25 | $1.0M | $26.5M | ||
| Q1 25 | $6.7M | $50.9M | ||
| Q4 24 | $-16.2M | $-341.0K | ||
| Q3 24 | $-8.4M | $6.2M | ||
| Q2 24 | $-625.0K | $12.7M | ||
| Q1 24 | $2.9M | $2.3M |
自由现金流率
DOMO
NUTX
| Q4 25 | 1.4% | 45.5% | ||
| Q3 25 | 1.3% | 37.0% | ||
| Q2 25 | 1.3% | 10.9% | ||
| Q1 25 | 8.5% | 24.0% | ||
| Q4 24 | -20.3% | -0.1% | ||
| Q3 24 | -10.7% | 7.8% | ||
| Q2 24 | -0.8% | 16.7% | ||
| Q1 24 | 3.6% | 3.4% |
资本支出强度
DOMO
NUTX
| Q4 25 | 2.9% | 0.9% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 3.7% | 0.3% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 3.2% | 0.2% | ||
| Q3 24 | 2.8% | 0.8% | ||
| Q2 24 | 3.2% | 0.7% | ||
| Q1 24 | 3.1% | 1.1% |
现金转化率
DOMO
NUTX
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |